In today’s complex benefits landscape, employers face mounting challenges in managing healthcare costs, designing effective plans, and engaging employees. With healthcare costs projected to rise 8% in ...

Ruxolitinib demonstrated sustained efficacy and improved quality of life in myelofibrosis patients in a real-world setting. The JAKoMo study reported fewer adverse events than clinical trials, ...

In today’s ultra-competitive global marketplace, life sciences companies are continually seeking ways to improve their research effectiveness and efficiency. Increasingly, real-world data (RWD) is ...

Enhertu showed better outcomes in HR-positive, HER2-negative breast cancer, while Trodelvy was more effective in HR-negative, HER2-null tumors when used first. Real-world data from over 4,000 patients ...

Patients with early Alzheimer’s disease (AD) who initiated lecanemab treatment at a specialty memory clinic showed an expected and manageable side-effect profile, new research showed. “The findings ...

Tirzepatide produced significant weight loss, reduced insulin requirements, and improved glucose control without increasing hypoglycemia when used off-label in adults with type 1 diabetes (T1D), new ...

As AI becomes more common and decisions more data-driven, a new(ish) form of information is on the rise: synthetic data. And some proponents say it promises more privacy and other vital benefits. Data ...